PetMed Express (NASDAQ:PETS) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $0.12 by 333.33 percent. This is a 83.03 percent increase over losses of $(1.65) per share from the same period last year. The company reported quarterly sales of $41.015 million which beat the analyst consensus estimate of $10.336 million by 296.82 percent. This is a 19.86 percent decrease over sales of $51.180 million the same period last year.